Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s traded shares stood at 2.2 million during the last session, with the company’s beta value hitting 1.91. At the close of trading, the stock’s price was $28.33, to imply a decrease of -5.25% or -$1.57 in intraday trading. The TNXP share’s 52-week high remains $658.24, putting it -2223.47% down since that peak but still an impressive 76.14% since price per share fell to its 52-week low of $6.76.
Analysts have given a consensus recommendation of Buy for Tonix Pharmaceuticals Holding Corp (TNXP), translating to a mean rating of 1.00. Of 5 analyst(s) looking at the stock, 0 analyst(s) give TNXP a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 4 recommend it as a Buy.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
After registering a -5.25% downside in the last session, Tonix Pharmaceuticals Holding Corp (TNXP) has traded red over the past five days. The 5-day price performance for the stock is 28.31%, and 89.37% over 30 days. With these gigs, the year-to-date price performance is -14.10%.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Tonix Pharmaceuticals Holding Corp (TNXP) shares. Going by data provided on Mar 31, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 31.04 shares. This is just over 0.42% of the total shares, with a market valuation of $0.88 million. Data from the same date shows that the other fund manager holds a little less at 10.5, or 0.14% of the shares, all valued at about 0.3 million.